Form Health

As Dr. Emily Smith MD explains, the initial results from the SURMOUNT-1 trial highlight the significant impact that treating obesity can have on preventing or resolving weight-related comorbidities. Is your organization seeking a partner to help address the high costs of obesity and metabolic diseases? Contact us at employers@formhealth.co to learn how we can help.

I appreciate Evan Richardson's honest take on the motivation behind using compounded medications. These companies will cite "improving health equity" as a reason to provide compounded medications in an attempt to obscure the obvious financial motivation and potentially puts patients at an unnecessary risk for harm. I agree that we need better access to effective anti-obesity medications (to be used under medical supervision with comprehensive lifestyle changes) but not at the risk to patients. Compounded drugs pose a higher risk to patients than FDA-approved drugs because compounded drugs do not undergo FDA premarket review for safety, quality or effectiveness. This article from Bloomberg (see below) has a great example of this very practice: "With brand-name weight-loss drugs costing over $1,000 a month, telehealth providers are luring in customers with lower prices. For $249 a month, Henry Meds offers a membership that includes dissolving tablets* or droplets* of semaglutide. The company also offers subscriptions for injectable drugs for more money....When [Steven Peacock, chief medical officer of Henry Meds was] asked what data Henry Meds has to show their dissolving drugs are as effective as the shots, he didn’t provide any." *There are currently no FDA-approved "dissolving tablets/droplets" of semaglutide. Rybelsus is an FDA-approved oral semaglutide tablet that you swallow (not designed to dissolve on the tongue). Bloomberg: https://lnkd.in/gKKaAVFH FDA: https://lnkd.in/g2gi8jkN

Meet Form Health Registered Dietitian Emily Burke, RD, CSOWM. She loves creating meaningful connections with patients across the country though her work at Form Health. If you're driven to transform healthcare and assist patients in reaching their weight loss and health goals, we'd love to have you on our team of obesity medicine specialists! Check out our career opportunities: https://lnkd.in/dZUp2V6p

Form Health CEO, Evan Richardson recently spoke with Modern Healthcare about the growing number of telehealth companies offering compounded GLP-1. He says, "This is extremely questionable from a safety perspective, and is a push for them to keep that channel open and keep that line of business open. I think it is quite transparently nothing more than that." At Form Health, patient safety is our top priority. We do not endorse the use of compounded drugs due to significant quality and safety concerns. Form Health providers only prescribe FDA-approved medications, if clinically appropriate. Is your organization looking for an obesity solution that prioritizes patient safety? Contact us at employers@formhealth.co to learn how we can help.

Articles like these highlight how important is to be under close medical supervision while taking weight loss medications. I've seen these medications in combination with comprehensive lifestyle changes and cognitive behavioral therapy lead to dramatic improvement in (and even resolution of) binge eating disorder, and it is life changing for these patients. Nevertheless, it is crucial to be on the lookout for signs of restrictive eating behaviors and intervene sooner rather than later. To learn more about eating disorders and treatment resources, check out National Eating Disorders Association (https://lnkd.in/g23N2Tyq). https://lnkd.in/gdYkbFEN

Form Health Chief Medical Officer Florencia Halperin comments on recent research that highlights a fascinating link between the brain and intestinally-derived hormonal signals. Although more research is needed to fully understand this connection, these findings underscore the potential of GLP-1s to enhance health outcomes beyond weight loss. At Form Health, our ABOM doctors leverage the latest science as they treat obesity with an evidence-based, comprehensive approach. Is your organization looking for an impactful and cost-effective strategy to manage the high costs of obesity and metabolic disease? Contact us at employers@formhealth.co to learn how we can help.

Physician Emily Smith MD shares how working at Form Health allows her to provide advanced care to patients who might not otherwise have access to specialized obesity treatment. Are you excited about making a difference in healthcare and helping patients achieve their weight loss and health goals? Join our team of obesity medicine specialists! Explore our job opportunities: https://lnkd.in/dZUp2V6p

Dr. Florencia Halperin, Chief Medical Officer at Form Health comments on the early SUMMIT Phase 3 results and highlights that treating obesity is about more than weight loss. It's at the center of effectively treating cardio-metabolic disease. At Form Health, our obesity medicine specialists treat obesity with a comprehensive, science-based approach that promotes weight loss and improved health. Is your organization seeking an impactful and cost-effective solution to address the high cost of obesity and its weight-related health conditions? Contact us at employers@formhealth.co to learn how we can help.

Form Health CEO, Evan Richardson, is featured on this week's Slice of Healthcare podcast with host Jared S. Taylor. In this episode, they discuss the rapidly evolving obesity medicine landscape and Form Health’s commitment to providing high-quality patient care and outcomes. They cover topics including, the impact of GLP-1s, the dangers of compounded medications, the importance of specialized treatment, and how telemedicine is transforming patient care. Find out how Form Health is leading the way in obesity medicine and shaping the future of treatment. Listen here:

As Form Health Chief Medical Officer Florencia Halperin points out, our team is committed to providing safe and effective clinical obesity care for our patients. That's why we only prescribe FDA-approved medication. Form Health does not endorse the use of compounded drugs for weight loss given quality and safety concerns. At Form Health, we treat obesity as a chronic disease with a science-based, comprehensive approach. Is your organization seeking an impactful and cost-effective solution to address the high cost of obesity and metabolic disease? Contact employers@formhealth.co to learn how we can help.